Metcela Inc.

Metcela Inc. ...

Based based in Tokyo, Japan, Metcela Inc. works in medical engineering & biotechnology.

Profile

"Metcela is a clinical-stage biotech startup focused on maximizing the potential of cells, particularly in the treatment of heart failure. Their technology revolves around VCAM-1-positive Cardiac Fibroblast (VCF), which stimulates the growth and movement of myocardial cells, leading to the formation of robust heart tissue. This enables the development of regenerative medical products using the patient's own cells. With recent news of a former Bayer Pharmaceuticals leader joining as an external director, Metcela is strengthening its global presence and enhancing the development of its clinical pipeline. Recognized in various media outlets for their innovative approach in the field of cell therapy, Metcela's pioneering technology and global expansion strategy are poised to deliver promising results in the realm of regenerative medicine."

Within the medical engineering & biotechnology space, the company focuses on its core offering rather than a broad product line.

The business is associated with Tokyo, Japan.

Its current recorded stage is J-Startup selected company.

The company reports a headcount in the 11-50 range.

Website: www.metcela.com